NIAMS Clinical Trial Implementation Cooperative Agreement (U01)

Post Date

May 27th 2011

Application Due Date

March 3rd 2014

Funding Opportunity Number

PAR-11-219

CFDA Number(s)

93.846

Funding Instrument Type(s)

Cooperative Agreement

Funding Activity Categories

Health

Eligibility Categories

State Governments
County Governments
City or Township Governments
Special District Governments
Independent School Districts
Public and State Controlled Institutions of Higher Education
Federally Recognized Native American Tribal Governments
Public Housing Authorities or Indian Housing Authorities
Non-Federally Recognized Native American Tribal Organizations
Non-Profits With 501 (c) (3) Status With The IRS (Except Higher Education Institutions)
Non-Profits Without 501 (c) (3) Status With The IRS (Except Higher Education Institutions)
Private Institutions of Higher Education
For-Profit Organizations (Except Small Businesses)
Small Businesses
Other

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Foreign (non-U.S.) components of U.S. Organizations are not allowed.

Funding

• Award Range:

  $None - $None

Grant Description

This Funding Opportunity Announcement (FOA) issued by the NIAMS invites cooperative agreement (U01) applications for implementation of investigator -initiated interventional clinical trials (all phases). This U01 FOA, which allows for the electronic submission of applications for single-site projects, compliments the previously released UM1 FOA, which permits submission of paper applications for multi-site projects. Applications for clinical trials submitted to the NIAMS are normally expected to go through a two-part process, which begins with a U34 planning phase (Part 1) followed by an application for the U01. Investigators who have completed all necessary pre-trial planning and preparation through other means may also apply for a NIAMS U01. Consultation with NIAMS staff is strongly encouraged prior to the submission of the clinical trial implementation U01 application. The NIAMS expects such trials to be hypothesis driven, milestone-defined, related to the research mission of the NIAMS, and considered high-priority by the institute.

Contact Information

• Agency

  Department of Health and Human Services

• Office:

  National Institutes of Health

• Agency Contact:

  NIH OER Webmaster
  FBOWebmaster@OD.NIH.GOV
  

• Agency Mailing Address:

  If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

• Agency Email Address:

  FBOWebmaster@OD.NIH.GOV

• More Information:

  http://grants.nih.gov/grants/guide/pa-files/PAR-11-219.html